Home results
 

Keywords :   


Tag: results

Castle Brands bets on innovations as Q1 sales struggle - results

2016-08-10 13:06:00| Daily beverage news and comment - from just-drinks.com

Castle Brands has posted a lacklustre Q1 but said sales are expected to accelerate through the year as a number of new products roll out.

Tags: results sales brands castle

 

SPI reports record-breaking results for NPE2018 pre-draw

2016-08-10 01:49:51| Canadian Plastics Headlines

Pre-draw results show plastics industry investing heavily in future growth, SPI said. The post SPI reports record-breaking results for NPE2018 pre-draw appeared first on Canadian Plastics.

Tags: results reports spi reports results

 
 

Stock Spirits H1 results - Preview

2016-08-09 13:03:00| Daily beverage news and comment - from just-drinks.com

Tomorrow, Stock Spirits will release its interim results for the first six months of the year. Here, just-drinks takes a closer look at the company's performance in the three months to 30 June. 

Tags: results stock preview spirits

 

Suominen Reports Second Quarter Results

2016-08-09 12:00:00| Nonwovens Industry Breaking News

Sales down 4%.

Tags: results reports quarter suominen

 

Results from Mercks Phase 3 Study Evaluating ZEPATIER (elbasvir and grazoprevir) in Patients with Chronic Hepatitis C Receiving Treatment for Opioid Dependence Published in Annals of Internal Medicine

2016-08-08 23:05:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the publication of results from C-EDGE CO-STAR . C-EDGE CO-STAR is a Phase 3 trial evaluating the use of ZEPATIER (elbasvir and grazoprevir) 50mg/100mg tablets in patients with chronic hepatitis C (HCV) genotype (GT) 1, GT4 and GT6 infection receiving opioid agonist therapy (OAT) (methadone and buprenorphine), commonly used to treat opioid addiction. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orSarra Herzog, 201-669-6570orInvestor:Teri Loxam, 908-740-1986orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: in of results study

 

Sites : [296] [297] [298] [299] [300] [301] [302] [303] [304] [305] [306] [307] [308] [309] [310] [311] [312] [313] [314] [315] next »